Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Following people with freezing of gait to study causes, walking and falls

Observes people with freezing of gait, including Parkinson's disease, over time.

Plain-language title generated from the registry record
Registry title: Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)

Key facts

Where
Tianjin, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 85 years old?

Source: NCT07386015, who can take part

Where in China

  • Tianjin Huanhu HospitalTianjin, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Tianjin Huanhu Hospital
Trial code
NCT07386015
Record updated
10 March 2026
Original description
This study is a prospective, multicenter, observational cohort (patient registry) designed to better understand freezing of gait (FOG), a disabling walking problem that can occur in Parkinson's disease and other related neurological conditions.The purpose of this registry is to collect long-term clinical information from patients with freezing of gait or gait and balance problems, and to explore how different causes of FOG are related to symptoms, walking patterns, falls, disease progression, and outcomes over time. The study will include participants with Parkinson's disease and other conditions associated with freezing of gait.Participants will receive standard medical care as determined by their treating physicians. No experimental drugs or study-related treatments will be assigned as part of this registry. Clinical information will be collected during routine visits and follow-up assessments, including questionnaires, walking and balance evaluations, video recordings, and other commonly used clinical tests.The information collected in this study may help improve the understanding of freezing of gait, support better risk assessment for falls, and guide future research and clinical management strategies for patients with gait and balance disorders.Read full original descriptionShow less

FREEZE-Path Cohort: Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)

This study is a prospective, multicenter, observational cohort (patient registry) designed to better understand freezing of gait (FOG), a disabling walking problem that can occur in Parkinson's disease and other related neurological conditions.The purpose of this registry is to collect long-term clinical information from patients with freezing of gait or gait and balance problems, and to explore how different causes of FOG are related to symptoms, walking patterns, falls, disease progression, and outcomes over time. The study will include participants with Parkinson's disease and other conditions associated with freezing of gait.Participants will receive standard medical care as determined by their treating physicians. No experimental drugs or study-related treatments will be assigned as part of this registry. Clinical information will be collected during routine visits and follow-up assessments, including questionnaires, walking and balance evaluations, video recordings, and other commonly used clinical tests.The information collected in this study may help improve the understanding of freezing of gait, support better risk assessment for falls, and guide future research and clinical management strategies for patients with gait and balance disorders.

Inclusion: Age 30-85 years; Presence of freezing of gait or non-freezing gait or balance impairment; Diagnosis of Parkinson's disease or related parkinsonian disorders according to established international criteria (including PD, PSP, MSA, DLB, CBD, vascular parkinsonism, or idiopathic normal pressure hydrocephalus); Ability to complete gait and balance assessment tasks independently or with assistance; Ability and willingness to provide written informed consent.

Exclusion: Severe dementia (Mini-Mental State Examination score < 10); Severe psychiatric disorders interfering with study participation; Severe cardiopulmonary, musculoskeletal, or other medical conditions significantly affecting gait safety; Stroke, fracture, or other major medical events within the past 3 months; Inability to comply with follow-up procedures; Refusal of video or speech data collection.

ClinicalTrials.gov NCT07386015